SAN DIEGO, Jan. 28, 2016 /PRNewswire/ -- With continuing pressure on the livestock and agriculture industry to provide a healthy, abundant food supply, there is a strong need to develop innovations that achieve solutions for a rapidly growing human population – one expected to reach nine billion by 2050. At the National Cattlemen's Beef Association (NCBA) Cattle Industry Convention, Bayer announced its continued focus on breakthrough discoveries and its latest developments.
"It takes true life science innovations to tackle the challenges facing agriculture and the world," said Kerryann Kocher, senior director, Food Animal Products, Bayer Animal Health. "At Bayer, innovation is central to our culture. That's why our business portfolio focuses exclusively on life sciences by addressing these challenges, from pharmaceuticals and consumer health to animal health and crop science. None of our peers are in a similar position."
As we enter 2016, Bayer is focused on delivering this innovation through the introduction of key products in the animal health space, created to help address two of cattle producers' top health concerns – bovine respiratory disease (BRD) and ecto-parasites.
Leading the Way with a Portfolio of Treatment Options for BRD
Although there are several effective antibiotics and vaccines to help combat bovine respiratory disease, or BRD, it remains an ongoing battle and costs the industry more than $1 billion annually in the United States alone. Enter Zelnate® DNA Immunostimulant, a new innovation in animal health from Bayer that changes the way veterinarians and producers are able to approach BRD.
Based on its expertise and long-time commitment to treating BRD, Bayer formulated Zelnate with a unique composition that rapidly triggers the animal's innate immune system, preparing it to better fight infection when challenged by BRD. Zelnate is not an antibiotic nor is it a vaccine. Antibiotics are used for treatment by selectively targeting specific bacterial pathogens. Vaccines are used for preventing disease by triggering a specific immune response only to those pathogens included in the vaccine. DNA Immunostimulants are a new way to fight BRD by jumpstarting the innate immune system and enhancing the body's own ability to respond quickly and effectively.
Bayer also is launching Loncor™ 300 (florfenicol) Injectable Solution, the newest addition to the Bayer BRD treatment line. Loncor 300 can effectively treat and control BRD in high-risk cattle as well as treat foot rot in beef and non-lactating dairy cattle. Florfenicol is the active ingredient in Loncor 300, which can be administered either subcutaneously or intramuscularly.
The developments expand Bayer's extensive BRD treatment portfolio, which includes Baytril® 100 (enrofloxacin) Injectable. Since its introduction, more than 50 million cattle have been treated with Baytril 100 in the United States alone. Bayer continues to invest in Baytril 100 to maximize its value in the marketplace, bringing several label additions for beef, dairy and swine throughout its lifecycle.
"Bayer is expanding its product portfolio to provide additional options to combat bovine respiratory disease," said Dr. Jim Little, senior technical veterinarian, Bayer Animal Health. "The variety of treatment options from Bayer not only makes the job easier for producers, but also arms them with some of the best tools possible for keeping their livestock and livelihood healthy."
Creating New Insecticide Products
But the focus on innovation at Bayer isn't limited to BRD as producers face additional challenges as well. In fact, insects can wreak havoc on the productivity of a cattle operation, transmitting disease and disrupting feeding (and ultimately animal weight gain). To help producers combat pest-related problems, Bayer has focused on delivering new pest management options to producers.
"Bayer is focused on quality as well as quantity to provide a variety of options in our Defense Point System," said Kocher. "We are proud to offer a specific strategy to help producers protect their livestock operation from pests and the damage they can cause."
These new options include:
- Tolfenpro™ Insecticide Ear Tag, a new ear tag containing Tolfenpyrad, a novel active ingredient not found in any other ear tag or livestock insecticide form. Tolfenpro helps producers control horn flies and face flies in cattle and provides a new option to fight pests, including those that may have become pyrethroid- and organophosphate-resistant.
- Clean-Up™ II Pour-On Insecticide is the combination of an insecticide with an insect growth regulator (IGR) for topical application to control biting and sucking lice on dairy and beef cattle and calves. Clean-Up II can be used directly on the animal and requires only one application to kill adult lice, eggs (nits) and nymphs. It also has a zero-day pre-slaughter interval and milk discard time.
- DeltaGard®, a new ultra low-volume cold fog insecticide, helps producers treat pests quickly and effectively. In addition to having the lowest amount of active applied compared to other insecticides, it also can be applied in and around livestock facilities with or without livestock present. DeltaGard provides a treatment option for quick knock down of stable flies and other pests listed on the label.
"These innovative additions to the treatment regimen will change the game in combatting BRD and ecto-parasites," said Dr. Larry Hawkins, senior technical veterinarian, Bayer Animal Health. "As diseases evolve, it is imperative that we stay ahead of the curve. Bayer is continually improving the future for producers and the communities they serve with cutting-edge product development."
At Bayer, this product development isn't just about launching new products, but also about bringing new molecules and true innovation to producers.
Consider this, Bayer is the only company:
- with combined animal health and crop science expertise.
- with 18 years of experience using a single-dose fluoroquinolone.
- to bring new immunostimulant technology to the market to help fight bovine respiratory disease.
- with more than 10 active ingredients in livestock insecticides to help promote rotation among chemical classes.
- that continues to introduce new products and new active ingredients for the control of insects.
"Innovation such as this is central to our culture at Bayer," said Kocher. "At the end of the day, all the science we do and resulting products we introduce are focused on delivering a better life to producers and ultimately the world."
For more information about these products or to obtain a product label, call Bayer Veterinary Services at +1 (800) 422-9874 or visit www.BayerLivestock.com.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
About Baytril 100
Baytril® 100 (enrofloxacin) Injectable is the first fluoroquinolone FDA-approved for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
Baytril 100 is for use by or on the order of a licensed veterinarian. Extra-label use in food-producing animals is prohibited. Cattle intended for human consumption must not be slaughtered within 28 days from the last treatment. This product is not approved for female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
About Clean-Up II
Clean-Up™ II Pour-On Insecticide with IGR is for topical application to dairy/beef cattle and calves to provide control of chewing and sucking lice.
DeltaGard is an ultra-low volume premise spray for the control of flies and mosquitoes in and around poultry and livestock facilities.
About Loncor 300
Loncor 300 is indicated for the treatment of BRD and the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. It also is indicated for the treatment of bovine interdigital phlegmon, or foot rot, associated with Fusobacterium necrophorum and Bacteroides melaninogenicus in beef cattle and non-lactating dairy cattle.
Loncor 300 is for use by or on the order of a licensed veterinarian. Animals intended for human consumption must not be slaughtered within 28 days of the last intramuscular treatment or within 38 days of subcutaneous treatment.
Tolfenpro Insecticide Ear Tags are for use on beef and dairy cattle (including lactating) to control horn flies and face flies for up to five months.
Zelnate is indicated for use as an aid in the treatment of Bovine Respiratory Disease due to Mannheimia haemolytica in cattle four months of age or older, when administered at the time of, or within 24 hours after, a perceived stressful event.
This product is based on technology developed by Juvaris BioTherapeutics and is patent protected. Animal health applications are being exclusively developed by Bayer Animal Health and are the subject of Bayer patent applications.
©2016 Bayer, Shawnee Mission, Kansas 66201
Bayer (reg'd), the Bayer Cross (reg'd), Baytril®, Clean-Up™, DeltaGard®, Loncor™, Tolfenpro™ and Zelnate® are trademarks of Bayer.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bayer-puts-focus-on-bringing-innovation-to-livestock-producers-300211366.html
SOURCE Bayer Corporation